, Report on global monitoring, WHO. Susceptibility of Plasmodium falciparum to antimalarial drugs, 1996.
, World Health Organization, WHO. Global report on antimalarial efficacy and drug resistance, 2000.
Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, PLoS Med, vol.5, p.128, 2008. ,
Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis, Lancet Infect Dis, vol.14, pp.982-91, 2014. ,
The Vivax Surveyor: online mapping database for Plasmodium vivax clinical trials, Int J Parasitol, vol.7, pp.181-90, 2017. ,
Chloroquine resistance in Plasmodium falciparum, Am J Trop Med Hyg, vol.10, pp.317-337, 1961. ,
Plasmodium falciparum resistant to chloroquine in Cambodia, Am J Trop Med Hyg, vol.12, pp.840-843, 1963. ,
Epidemiology of drug resistance in malaria, Acta Trop, vol.56, pp.143-56, 1994. ,
Spread and evolution of Plasmodium falciparum drug resistance, Parasitol Int, vol.58, pp.201-210, 2009. ,
, , 2017.
Sulfadoxine-pyrimethamine resistant falciparum malaria from Cambodia, Dtsch Med Wochenschr, vol.105, pp.350-351, 1980. ,
Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand, Lancet, vol.1, pp.1068-70, 1981. ,
Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles, J Infect Dis, vol.194, pp.189-97, 2006. ,
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria, PLoS Med, vol.6, p.1000055, 2009. ,
Multiple origins of Plasmodium falciparum dihydropteroate synthetase mutant alleles associated with sulfadoxine resistance in India, Antimicrob Agents Chemother, vol.55, pp.2813-2820, 2011. ,
Tracking origins and spread of sulfadoxine-resistant Plasmodium falciparum dhps alleles in Thailand, Antimicrob Agents Chemother, vol.55, pp.155-64, 2011. ,
Intercontinental spread of pyrimethamine-resistant malaria, Science, vol.305, p.1124, 2004. ,
Type II mefloquine resistance in Thailand, Lancet, vol.2, p.1335, 1982. ,
Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border. Antimicrob Agents Chemother, vol.37, pp.1977-81, 1993. ,
, Qinghaosu in combinations. Med Trop, vol.58, pp.85-93, 1998.
Preventing antimalarial drug resistance through combinations, Drug Resist Updates, vol.1, pp.3-9, 1998. ,
Artemisinin-based combinations, Curr Opin Infect Dis, vol.18, pp.531-537, 2005. ,
, Guidelines for the treatment of malaria. Geneva, World Health Organization, 2010.
, WorldWide Antimalarial Resistance Network (WWARN) DP Study Group. The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data, PLoS Med, vol.10, p.1001564, 2013.
, Worldwide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group. The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data, Lancet Infect Dis, vol.15, pp.692-702, 2015.
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data, BMC Med, vol.13, p.66, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02560653
Artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.361, pp.455-67, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-02427334
Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia, Clin Infect Dis, vol.51, pp.82-91, 2010. ,
Spread of artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.371, pp.411-434, 2014. ,
Dihydroartemisinin-piperaquine failure in Cambodia, N Engl J Med, vol.371, pp.484-489, 2014. ,
Plasmodium falciparum resistance to artemisinin derivatives and piperaquine: a major challenge for malaria elimination in Cambodia, Am J Trop Med Hyg, vol.95, pp.1228-1266, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02560596
Antimalarial drug resistance: a threat to malaria elimination. Cold Spring Harb Perspect Med, vol.7, p.25619, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02559309
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, vol.505, pp.50-55, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00921203
K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates, Science, vol.347, pp.428-459, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01925134
A worldwide map of Plasmodium falciparum K13-propeller polymorphisms, N Engl J Med, vol.374, pp.2453-64, 2016. ,
Independent Emergence of the Plasmodium falciparum Kelch Propeller Domain Mutant Allele C580Y in Guyana, J. Infect. Dis, vol.213, pp.1472-1477, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02862975
Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia, J Infect Dis, vol.211, pp.670-679, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02560668
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread, FEMS Microbiol Rev, vol.41, pp.34-48, 2017. ,
Malaria medicines: a glass half full?, Nat Rev Drug Discov, vol.14, pp.424-466, 2015. ,
Alternatives to currently used antimalarial drugs: in search of a magic bullet, Infect Dis Poverty, vol.5, p.103, 2016. ,
World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs, Malar J, vol.6, p.119, 2007. ,
Lessons learnt from 20 years surveillance of malaria drug resistance prior to the policy change in Burkina Faso, Ann Parasitol, vol.62, pp.17-24, 2016. ,
, Minutes of the Evidence Review Group meeting on the emergence and spread of multidrug-resistant Plasmodium falciparum lineages in the Greater Mekong subregion. Geneva, World Health Organization, 2016.
, Methods for surveillance of antimalarial drug efficacy. Geneva, World Health Organization, 2009.
, Report of a WHO scientific group. Geneva, World Health Organization, 1965.
, Assessment of therapeutic efficacy of antimalarial drugs. for uncomplicated falciparum malaria in areas with intense transmission
, , 1996.
, Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva, World Health Organization, 2003.
Methods and techniques for clinical trials on antimalarial drug efficacy: Genotyping to identify parasite populations. Geneva, World Health Organization, 2008. ,
Simplified antimalarial therapeutic monitoring: using the day-7 drug level?, Trends Parasitol, vol.24, pp.159-63, 2008. ,
, Methods and techniques for assessing exposure to antimalarial drugs in clinical field studies. Geneva, World Health Organization, 2011.
Variation of Plasmodium falciparum msp1 block 2 and msp2 allele prevalence and of infection complexity in two neighbouring Senegalese villages with different transmission conditions, Trans R Soc Trop Med Hyg, vol.93, issue.1, pp.21-29, 1999. ,
Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials, Antimicrob Agents Chemother, vol.51, pp.3096-103, 2007. ,
Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness, Trop Med Int Health, vol.11, pp.1350-1359, 2006. ,
Critical evaluation of molecular monitoring in malaria drug efficacy trials and pitfalls of length-polymorphic markers, Antimicrob Agents Chemother, vol.61, pp.1500-1516, 2017. ,
Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections, Am J Trop Med Hyg, vol.75, pp.836-878, 2006. ,
Comparison of PCR-RFLP and Genescan-based genotyping for analyzing infection dynamics of Plasmodium falciparum, Am J Trop Med Hyg, vol.74, pp.944-50, 2006. ,
Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2), Malar J, vol.8, p.78, 2009. ,
Microsatellite analysis of malaria parasites, Methods Mol Biol, vol.1006, pp.247-58, 2013. ,
Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum, Mol Biol Evol, vol.17, pp.1467-82, 2000. ,
A better resolution for integrating methods for monitoring Plasmodium falciparum resistance to antimalarial drugs, Acta Trop, vol.137, pp.44-57, 2014. ,
Plasmodium falciparum genotyping by microsatellites as a method to distinguish between recrudescent and new infections, Am J Trop Med Hyg, vol.73, pp.210-213, 2005. ,
A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking, Malar J, vol.7, p.223, 2008. ,
Monitoring and deterring drugresistant malaria in the era of combination therapy, Am J Trop Med Hyg, vol.77, pp.160-169, 2007. ,
Monitoring antimalarial drug efficacy: current challenges, Curr Infect Dis Rep, vol.11, pp.59-65, 2009. ,
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo, Antimicrob Agents Chemother, vol.41, pp.1413-1435, 1997. ,
Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization, Antimicrob Agents Chemother, vol.57, pp.5792-807, 2013. ,
Antimalarial pharmacokinetics and treatment regimens, Br J Clin Pharmacol, vol.34, pp.1-10, 1992. ,
Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and metaanalysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data, BMC Med, vol.13, p.227, 2015. ,
Population pharmacokinetic properties of piperaquine in falciparum malaria: an individual participant data meta-analysis, PLoS Med, vol.14, p.1002212, 2017. ,
Human malaria parasites in continuous culture, Science, vol.193, pp.673-678, 1976. ,
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in vitro and ex vivo drugresponse studies, Lancet Infect Dis, vol.13, pp.1043-1052, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00863935
, , vol.2, p.30, 2003.
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool, Antimicrob Agents Chemother, vol.57, pp.3121-3151, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00861904
World Health Organization. Field application of in vitro assays sensitivity of human malaria parasites antimalarial drugs. Geneva: World Health Organization, 2007. ,
Drug sensitivity of Plasmodium falciparum. An in vitro microtechnique, Lancet, vol.1, pp.22-25, 1978. ,
, In vitro micro-test (mark III) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, amodiaquine, sulfadoxine/pyrimethamine and artemisinin. Geneva, World Health Organization, 2001.
Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique, Antimicrob Agents Chemother, vol.16, pp.710-718, 1979. ,
Plasmodium falciparum: assessment of in vitro growth by [3H] hypoxanthine incorporation, Exp Parasitol, vol.55, pp.138-184, 1983. ,
Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia, Am J Trop Med Hyg, vol.48, pp.205-215, 1993. ,
Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity, Am J Trop Med Hyg, vol.48, pp.739-780, 1993. ,
Histidine-rich protein II: a novel approach to malaria drug sensitivity testing, Antimicrob Agents Chemother, vol.46, pp.1658-64, 2002. ,
Evaluation of in vitro drug sensitivity of antimalarials for Plasmodium falciparum using a colorimetric assay (DELI-microtest), Med Trop, vol.61, pp.545-552, 2001. ,
Malaria drug-susceptibility testing. HRP2-based assays: current data, future perspectives, Wien Klin Wochenschr, vol.115, pp.23-30, 2003. ,
Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother, vol.51, pp.1926-1959, 2007. ,
Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria, Cytometry, vol.27, pp.84-91, 1997. ,
Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry, Malar J, vol.14, p.417, 2015. ,
Comparison between flow cytometry, microscopy, and lactate dehydrogenase-based enzyme-linked immunosorbent assay for Plasmodium falciparum drug susceptibility testing under field conditions, J Clin Microbiol, vol.53, pp.3296-303, 2015. ,
Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in Western Cambodia, Antimicrob Agents Chemother, vol.57, pp.914-937, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02378668
Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism, Antimicrob Agents Chemother, vol.54, pp.1872-1879, 2010. ,
Flow cytometry-based analysis of artemisinin-resistant Plasmodium falciparum in the ring-stage survival assay, Antimicrob Agents Chemother, vol.58, pp.4938-4978, 2014. ,
A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria, Malar J, vol.8, p.89, 2009. ,
Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum, Nature, vol.345, pp.255-263, 1990. ,
Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance, Mol Cell, vol.6, pp.861-71, 2000. ,
A molecular marker for chloroquine-resistant falciparum malaria, N Engl J Med, vol.344, pp.257-63, 2001. ,
Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria, Proc Natl Acad Sci USA, vol.87, pp.3018-3040, 1990. ,
Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea, Am J Trop Med Hyg, vol.55, pp.209-222, 1996. ,
Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization, Mol Microbiol, vol.23, pp.979-86, 1997. ,
Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine, Proc Natl Acad Sci, vol.91, pp.1143-1150, 1994. ,
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number, Lancet, vol.364, pp.438-485, 2004. ,
Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site, Antimicrob Agents Chemother, vol.44, pp.2100-2108, 2000. ,
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study, Lancet Infect Dis, vol.17, pp.174-83, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01400955
Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotypephenotype association study, Lancet Infect Dis, vol.17, pp.164-73, 2017. ,
Comparative assessment of genomic DNA extraction processes for Plasmodium: identifying the appropriate method, J Vector Borne Dis, vol.52, pp.273-80, 2015. ,
Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion, Exp Parasitol, vol.89, pp.1-8, 1998. ,
Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion, Exp Parasitol, vol.80, pp.483-490, 1995. ,
DNA sequencing with chain-terminating inhibitors, Proc Natl Acad Sci USA, vol.74, pp.5463-5470, 1977. ,
Genetic architecture of artemisinin-resistant Plasmodium falciparum, Nat Genet, vol.47, pp.226-260, 2015. ,
Pooled deep sequencing of Plasmodium falciparum isolates: an efficient and scalable tool to quantify prevailing malaria drug-resistance genotypes, J Infect Dis, vol.208, pp.1998-2006, 2013. ,
Detecting selection signals in Plasmodium falciparum using identity-by-descent analysis, BioRxiv, 2016. ,
Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum, Antimicrob Agents Chemother, vol.54, pp.2455-64, 2010. ,
A new method for detection of pfmdr1 mutations in Plasmodium falciparum DNA using real-time PCR, Malar J, vol.3, p.9, 2004. ,
Optimization of a ligase detection reaction-fluorescent microsphere assay for characterization of resistance-mediating polymorphisms in African samples of Plasmodium falciparum, J Clin Microbiol, vol.51, pp.2564-70, 2013. ,
Detection of single-nucleotide polymorphisms in Plasmodium falciparum by PCR primer extension and lateral flow immunoassay, Antimicrob Agents Chemother, vol.59, pp.365-71, 2015. ,
, , 2017.
Travellers as sentinels: assaying the worldwide distribution of polymorphisms associated with artemisinin combination therapy resistance in Plasmodium falciparum using malaria cases imported into Scotland, Int J Parasitol, vol.43, pp.885-894, 2013. ,
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, Malar J, vol.12, p.35, 2000. ,
URL : https://hal.archives-ouvertes.fr/inserm-00795004
The rationale and plan for creating a World Antimalarial Resistance Network (WARN), Malar J, vol.6, p.118, 2007. ,
Monitoring antimalarial resistance: launching a cooperative effort, Trends Parasitol, vol.26, pp.221-225, 2010. ,
Microscopy for the detection, identification and quantification of malaria parasites on stained thick and thin blood films in research settings. Geneva, World Health Organization, 2015. ,
Computational microscopic imaging for malaria parasite detection: a systematic review, J Microsc, vol.260, pp.1-19, 2015. ,
Computer-vision-based technology for fast, accurate and cost effective diagnosis of malaria, Malar J, vol.14, p.526, 2015. ,
Evaluation of the Parasight Platform for Malaria Diagnosis, J. Clin. Microbiol, vol.55, pp.768-75, 2017. ,
The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995-2005, Malar J, vol.5, p.122, 2006. ,
Robust algorithm for systematic classification of malaria late treatment failures as recrudescence or reinfection using microsatellite genotyping, Antimicrob Agents Chemother, vol.59, pp.6096-100, 2015. ,
Malaria drug-sensitivity testing: new assays, new perspectives, Trends Parasitol, vol.19, pp.175-81, 2003. ,
Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine, Am J Trop Med Hyg, vol.53, pp.639-684, 1995. ,
Growth, drug susceptibility, and gene expression profiling of Plasmodium falciparum cultured in medium supplemented with human serum, J Biomol Screen, vol.12, pp.1109-1123, 2007. ,
The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya, Am J Trop Med Hyg, vol.62, pp.396-401, 2000. ,
In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003, Malar J, vol.4, p.37, 2005. ,
Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia, Malar J, vol.12, p.239, 2013. ,
Comparison of a SYBR green I-based assay with a histidine-rich protein II enzymelinked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates, Antimicrob Agents Chemother, vol.51, pp.1172-1180, 2007. ,
Assessment of SYBR green I dye-based fluorescence assay for screening antimalarial activity of cationic peptides and DNA intercalating agents, Antimicrob Agents Chemother, vol.59, pp.2886-2895, 2015. ,
Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening, Antimicrob Agents Chemother, vol.48, pp.1803-1809, 2004. ,
The effect of storage and extraction methods on amplification of Plasmodium falciparum DNA from dried blood spots, Am J Trop Med Hyg, vol.92, pp.922-927, 2015. ,
SYBR green I and Taqman quantitative real-time polymerase chain reaction methods for the determination of amplification of Plasmodium falciparum multidrug resistance-1 gene (PFMDR1), J Parasitol, vol.97, pp.939-981, 2011. ,
A global network for investigating the genomic epidemiology of malaria, Nature, vol.456, pp.732-739, 2008. ,
, Genomic epidemiology of artemisinin resistant malaria, MalariaGEN Plasmodium falciparum Community Project, 2016.
, Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience, Trop Med Int Health, vol.6, pp.891-899, 2001.
, The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy, Trop Med Int Health, vol.8, pp.860-867, 2003.
Partnership to fight malaria in the Amazon, 2017. ,
Capacity development through the US President's malaria initiative-supported antimalarial resistance monitoring in Africa network. Emerg Infect Dis, 2017. ,